Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial.Xuewei Ding, Han Liang, Jingli Cui et al.|Journal of Clinical Oncology|2022Cited by 14
Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage <scp>IV</scp> gastric cancerYong Liu, Han Liang, Qiang Xue et al.|International Journal of Cancer|2025Cited by 3